[Drug therapy of Paget's disease (osteodystrophia deformans)].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D008926:Plicamycin / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014807:Vitamin D; D000324:Adrenocorticotropic Hormone; D002116:Calcitonin; D012968:Etidronic Acid; D008926:Plicamycin; D001241:Aspirin; D002118:Calcium; D003348:Cortisone
Die medikamentöse Behandlung des Morbus Paget (Osteodystrophia deformans)